Sentinel lymph node biopsy in patients with ductal carcinoma in situ: A proposal

Kelly M. McMasters, Celia Chao, Sandra L. Wong, Robert C.G. Martin, Michael J. Edwards

Research output: Contribution to journalReview article

44 Scopus citations

Abstract

Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.

Original languageEnglish (US)
Pages (from-to)15-20
Number of pages6
JournalCancer
Volume95
Issue number1
DOIs
StatePublished - Jul 1 2002
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

McMasters, K. M., Chao, C., Wong, S. L., Martin, R. C. G., & Edwards, M. J. (2002). Sentinel lymph node biopsy in patients with ductal carcinoma in situ: A proposal. Cancer, 95(1), 15-20. https://doi.org/10.1002/cncr.10641